ALNY
Alnylam Pharmaceuticals Inc.
$391.60
-$21.03(-5.10%)
53
Overall
40
Value
45
Tech
76
Quality
Market Cap
$59.82B
Volume
1.01M
52W Range
$205.87 - $495.55
Target Price
$501.52
EPS Estimates Overview
| Current Quarter | $1.05 | Next Quarter | $1.16 |
| Current Year | $1.84 | Next Year | $7.4 |
| QoQ Growth | +10.5% | YoY Growth | +302.2% |
| 3Y EPS CAGR | +32.9% | Target Price | $501.52 |
| Consensus | Buy | Upside | +28.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALNY | $391.60 | -5.1% | 1.01M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Alnylam Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW